- Home
- DARE vs HUIZ Comparison
DARE vs HUIZ Comparison
Compare DARE & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- HUIZ
- Stock Information
- Founded
- DARE 2015
- HUIZ 2006
- Country
- DARE United States
- HUIZ China
- Employees
- DARE N/A
- HUIZ N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- HUIZ Specialty Insurers
- Sector
- DARE Health Care
- HUIZ Finance
- Exchange
- DARE Nasdaq
- HUIZ Nasdaq
- Market Cap
- DARE 28.0M
- HUIZ 25.3M
- IPO Year
- DARE N/A
- HUIZ 2020
- Fundamental
- Price
- DARE $2.08
- HUIZ $2.67
- Analyst Decision
- DARE Strong Buy
- HUIZ Hold
- Analyst Count
- DARE 2
- HUIZ 1
- Target Price
- DARE $10.00
- HUIZ $2.30
- AVG Volume (30 Days)
- DARE 182.2K
- HUIZ 29.6K
- Earning Date
- DARE 08-14-2025
- HUIZ 09-12-2025
- Dividend Yield
- DARE N/A
- HUIZ N/A
- EPS Growth
- DARE N/A
- HUIZ N/A
- EPS
- DARE N/A
- HUIZ N/A
- Revenue
- DARE N/A
- HUIZ $168,454,627.00
- Revenue This Year
- DARE $74,787.57
- HUIZ $11.94
- Revenue Next Year
- DARE $141.76
- HUIZ $8.15
- P/E Ratio
- DARE N/A
- HUIZ N/A
- Revenue Growth
- DARE N/A
- HUIZ 1.28
- 52 Week Low
- DARE $1.83
- HUIZ $1.50
- 52 Week High
- DARE $9.19
- HUIZ $10.58
- Technical
- Relative Strength Index (RSI)
- DARE 44.08
- HUIZ 60.05
- Support Level
- DARE $2.00
- HUIZ $2.25
- Resistance Level
- DARE $2.19
- HUIZ $2.63
- Average True Range (ATR)
- DARE 0.09
- HUIZ 0.13
- MACD
- DARE 0.03
- HUIZ 0.02
- Stochastic Oscillator
- DARE 34.78
- HUIZ 84.18
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.